Cefepime - Bristol-Myers Squibb
Alternative Names: Axepim; BMY 28142; Maxcef; MaxipimeLatest Information Update: 05 Nov 2023
At a glance
- Originator Bristol-Myers Squibb
- Class Anti-infectives; Antibacterials; Cephalosporins; Small molecules
- Mechanism of Action Cell wall inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Bacterial infections; Febrile neutropenia; Intra-abdominal infections; Respiratory tract infections; Skin and soft tissue infections; Urinary tract infections